176 related articles for article (PubMed ID: 32822001)
21. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
[TBL] [Abstract][Full Text] [Related]
22. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
[TBL] [Abstract][Full Text] [Related]
23. CircPITX1 Regulates Proliferation, Angiogenesis, Migration, Invasion, and Cell Cycle of Human Glioblastoma Cells by Targeting miR-584-5p/KPNB1 Axis.
Cao Y; Wang F; Chen Y; Wang Y; Song H; Long J
J Mol Neurosci; 2021 Aug; 71(8):1683-1695. PubMed ID: 33763840
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity.
Liu B; Lin X; Yang X; Dong H; Yue X; Andrade KC; Guo Z; Yang J; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Chen Q; Mao S; Chen Q; Chang J
Cancer Med; 2015 Sep; 4(9):1404-16. PubMed ID: 26108681
[TBL] [Abstract][Full Text] [Related]
25. High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine Pathway.
Cheng P; Ma Y; Gao Z; Duan L
Med Sci Monit; 2018 Dec; 24():8916-8924. PubMed ID: 30531692
[TBL] [Abstract][Full Text] [Related]
26. SECTM1 promotes the development of glioblastoma and mesenchymal transition by regulating the TGFβ1/Smad signaling pathway.
Yao Z; Zhang F; Qi C; Wang C; Mao M; Zhao C; Qi M; Wang Z; Zhou G; Jiang X; Xia H
Int J Biol Sci; 2024; 20(1):78-93. PubMed ID: 38164182
[No Abstract] [Full Text] [Related]
27. LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling.
Xiao Q; Dong M; Cheng F; Mao F; Zong W; Wu K; Wang H; Xie R; Wang B; Lei T; Guo D
Int J Oncol; 2018 Sep; 53(3):1069-1082. PubMed ID: 30015847
[TBL] [Abstract][Full Text] [Related]
28. Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway.
Li Z; Chen Y; An T; Liu P; Zhu J; Yang H; Zhang W; Dong T; Jiang J; Zhang Y; Jiang M; Yang X
J Exp Clin Cancer Res; 2019 Mar; 38(1):139. PubMed ID: 30922391
[TBL] [Abstract][Full Text] [Related]
29. The role of microRNA-148a and downstream DLGAP1 on the molecular regulation and tumor progression on human glioblastoma.
Li Y; Li W; Zeng X; Tang X; Zhang S; Zhong F; Peng X; Zhong Y; Rosol TJ; Deng X; Liu Z; Peng S; Peng X
Oncogene; 2019 Nov; 38(47):7234-7248. PubMed ID: 31477833
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
[TBL] [Abstract][Full Text] [Related]
31. Repression of Septin9 and Septin2 suppresses tumor growth of human glioblastoma cells.
Xu D; Liu A; Wang X; Chen Y; Shen Y; Tan Z; Qiu M
Cell Death Dis; 2018 May; 9(5):514. PubMed ID: 29724999
[TBL] [Abstract][Full Text] [Related]
32. Repression of RhoJ expression promotes TGF-β-mediated EMT in human non-small-cell lung cancer A549cells.
Nozaki M; Nishizuka M
Biochem Biophys Res Commun; 2021 Aug; 566():94-100. PubMed ID: 34119829
[TBL] [Abstract][Full Text] [Related]
33. miRNA-448 Regulates the Development of Glioblastoma (GBM) by Regulating Rho-Associated Protein Kinase 1.
Liu C; Zhu B; Zhong M; Bao J
Comput Math Methods Med; 2022; 2022():2502010. PubMed ID: 35281946
[TBL] [Abstract][Full Text] [Related]
34. RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner.
Zhao K; Cui X; Wang Q; Fang C; Tan Y; Wang Y; Yi K; Yang C; You H; Shang R; Wang J; Kang C
Cell Death Dis; 2019 Nov; 10(12):877. PubMed ID: 31754093
[TBL] [Abstract][Full Text] [Related]
35. TAK-242 inhibits glioblastoma invasion, migration, and proneural-mesenchymal transition by inhibiting TLR4 signaling.
Feng Z; Chen G; Huang Y; Zhang K; Wu G; Xing W; Wu Y; Zhou Y; Sun C
Exp Cell Res; 2024 Jun; 439(1):114091. PubMed ID: 38740168
[TBL] [Abstract][Full Text] [Related]
36. miR‑96 inhibits EMT by targeting AEG‑1 in glioblastoma cancer cells.
Feng S; Yao J; Zhang Z; Zhang Y; Zhang Z; Liu J; Tan W; Sun C; Chen L; Yu X
Mol Med Rep; 2018 Feb; 17(2):2964-2972. PubMed ID: 29257267
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of miR-1825 inhibits the progression of glioblastoma by suppressing CDK14 though Wnt/β-catenin signaling pathway.
Lu F; Li C; Sun Y; Jia T; Li N; Li H
World J Surg Oncol; 2020 Jun; 18(1):147. PubMed ID: 32605563
[TBL] [Abstract][Full Text] [Related]
38. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.
Tu Y; Xie P; Du X; Fan L; Bao Z; Sun G; Zhao P; Chao H; Li C; Zeng A; Pan M; Ji J
J Cell Mol Med; 2019 Oct; 23(10):6907-6918. PubMed ID: 31430050
[TBL] [Abstract][Full Text] [Related]
39. Loss of cytoskeleton protein ADD3 promotes tumor growth and angiogenesis in glioblastoma multiforme.
Kiang KM; Zhang P; Li N; Zhu Z; Jin L; Leung GK
Cancer Lett; 2020 Apr; 474():118-126. PubMed ID: 31958485
[TBL] [Abstract][Full Text] [Related]
40. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
